Multi-supplier procurement and disaster preparedness and recovery measures at manufacturing sites
First written in FY2016. 8 of 14 entries say "Advanced", first in FY2020. Latest entry: 2026-10-01.
18 other companies' latest entry also says "Advanced".
- 2026-10-01AdvancedGovernance
「Going forward, we will expand the initiative nationwide and aim to reduce dry ice consumption in the transportation of major frozen products by at least 80% from fiscal 2021 levels by fiscal 2028.」
The company expanded dry-ice-free transportation to small-lot deliveries and disclosed a reduction target through fiscal 2028. - FY2026AdvancedAnnual report
「At the new Sysmex RA factory completed in the current fiscal year, the Group expanded production capacity through an enlarged production area and strengthened BCP functions enabling rapid backup even when an emergency occurs at another Group factory, by increasing raw-material inventory through automated in-factory logistics.」
The Sysmex RA factory, which had been at the planning stage in the previous disclosure, has been completed. The Group expanded production capacity and strengthened BCP functions through automated in-factory logistics and increased raw-material inventory. - 2026-05-29AdvancedGeneral Meetings of Shareholders
「We decided to relocate and expand our diagnostic reagent production plant in Brazil to expand our business in Central and South America and strengthen our product supply structure over the medium to long term.」
In addition to existing measures to maintain supply through multiple production sites and business continuity planning, the company added an integrated base in Brazil for diagnostic reagent production, logistics and technical services, together with backup functions at a U.S. site. - FY2024RestatedAnnual report
「Under normal conditions, the Group works to secure inventory of components, raw materials and other items and to use multiple sourcing, while enhancing preventive and recovery measures against major disasters such as earthquakes, storms and floods at factories and warehouses.」
The disclosure reiterates inventory, multiple sourcing, and disaster prevention and recovery measures at factories and warehouses as means of ensuring stable supply. - FY2024-Q3AdvancedAnnual report
「To strengthen its equipment production capabilities, the Group decided to relocate and expand the factory of Sysmex RA Co., Ltd., which is responsible for designing and producing specimen-testing transport system products and peripheral equipment essential to total clinical laboratory solutions. In addition to expanding the production area, the Group will approximately double production capacity by improving production efficiency through the standardization of components and units, greater flexibility in production lines and robot-based automation, while also establishing BCP functions for emergencies such as disasters affecting other Group factories.」
The Group decided to relocate and expand the Sysmex RA factory and specified plans to approximately double production capacity, standardize components and units, make production lines more flexible, introduce robot-based automation and establish BCP functions for emergencies affecting other factories. - FY2023AdvancedAnnual report
「The Group works to mitigate risks related to components, raw materials and other items by securing inventory and using multiple sourcing, and is enhancing disaster prevention and recovery measures at supply-chain sites.」
In addition to the existing measures of securing inventory, multiple sourcing and supply among sites, the disclosure explicitly identifies BCP inventory based on the recovery period and multiple production sites. - FY2022AdvancedAnnual report
「In particular, for diagnostic reagents, which accounted for 59.4% of Group sales in the fiscal year ended March 2022, the Group is working to maintain more than one month of safety stock and establish multiple production sites. For diagnostic reagents in the hematology field, its core business, it is also establishing a system for mutual supply among major sites in Europe, the Americas, China and Japan, in addition to multiple manufacturing sites through local production, to ensure continued supply.」
The disclosure adds China to the existing mutual-supply system covering Europe, the Americas and Japan and describes measures to ensure continued supply, including multiple manufacturing sites through local production. - FY2022-Q3RestatedAnnual report
「The Group works to mitigate risks related to components, raw materials and other items by securing inventory and using multiple sourcing, and is also enhancing disaster prevention and recovery measures at manufacturing sites. In particular, for diagnostic reagents, which accounted for 55.8% of Group sales in the fiscal year ended March 2021, it is working to maintain more than 1 month of safety stock and establish multiple production sites. For diagnostic reagents in the hematology field, its core business, it has also established a mutual-supply system among major sites in Europe, the Americas and Japan to ensure continued supply.」
The disclosure reiterates measures to ensure continued supply through inventory, multiple sourcing, safety stock, multiple production sites and mutual supply among major sites. - FY2022-Q2RestatedAnnual report
「The Group works to mitigate risks related to components, raw materials and other items by securing inventory and using multiple sourcing, and is also enhancing disaster prevention and recovery measures at manufacturing sites. In particular, for diagnostic reagents, which accounted for 55.8% of Group sales in the fiscal year ended March 2021, it is working to maintain more than 1 month of safety stock and establish multiple production sites. For diagnostic reagents in the hematology field, its core business, it has also established a mutual-supply system among major sites in Europe, the Americas and Japan to ensure continued supply.」
The disclosure reiterates measures to ensure continued supply through inventory, multiple sourcing, safety stock, multiple production sites and mutual supply among major sites. - FY2021AdvancedAnnual report
「For diagnostic reagents in the blood cell counting testing field, its core business, the Group has established a mutual-supply system among major sites in Europe, the Americas and Japan to ensure continued supply.」
In addition to at least 1 month of safety stock, multiple production sites, and multiple sourcing and stockpiling, the Group established a mutual-supply system among major sites in Europe, the Americas and Japan. - FY2020AdvancedAnnual report
「Accordingly, for diagnostic reagents in the blood cell counting testing field, the Group's core business, the Group is working to secure at least one month of safety stock and establish multiple production sites. It is also working to mitigate risks through multiple sourcing and stockpiling of raw materials, while enhancing disaster prevention and recovery measures at manufacturing sites.」
For diagnostic reagents in the blood cell counting field, the Group added at least 1 month of safety stock, multiple production sites, and multiple sourcing and stockpiling of raw materials as specific measures. - FY2018RestatedAnnual report
「Accordingly, the Group works to mitigate risks through multiple sourcing of raw materials and other measures, while enhancing disaster prevention and recovery measures at manufacturing sites.」
The disclosure reiterates multiple sourcing and preventive and recovery measures at manufacturing sites. - FY2017RestatedAnnual report
「Accordingly, the Group works to mitigate risks through multiple sourcing of raw materials and other measures, while enhancing disaster prevention and recovery measures at manufacturing sites.」
The disclosure reiterates multiple sourcing and preventive and recovery measures at manufacturing sites. - FY2016First statedAnnual report
「Accordingly, the Group works to mitigate risks through multiple sourcing of raw materials and other measures, while enhancing disaster prevention and recovery measures at manufacturing sites.」
The Group uses diversified sourcing and preventive and recovery measures at manufacturing sites to ensure stable supply.